000			01609 a2200457 4500
005			20250513083648.0
264		0	_c19960202
008			199602s 0 0 spa d
022			_a0025-7753
040			_aNLM _beng _cNLM
100	1		_aPorcel, J M
245	0	0	_a[Complement inhibition: a new therapeutic modality?]. _h[electronic resource]
260			_bMedicina clinica _cNov 1995
300			_a700-2 p. _bdigital
500			_aPublication Type: Editorial
650	0	4	_aAdult
650	0	4	_aAnimals
650	0	4	_aAntigens, CD _xtherapeutic use
650	0	4	_aBenzamidines
650	0	4	_aBlood Proteins _xtherapeutic use
650	0	4	_aCD55 Antigens _ximmunology
650	0	4	_aCD59 Antigens _ximmunology
650	0	4	_aCarrier Proteins _xtherapeutic use
650	0	4	_aComplement Activation
650	0	4	_aComplement Inactivator Proteins _xtherapeutic use
650	0	4	_aComplement Membrane Attack Complex _ximmunology
650	0	4	_aComplement System Proteins _ximmunology
650	0	4	_aCoronary Disease _xdrug therapy
650	0	4	_aDermatomyositis _xdrug therapy
650	0	4	_aElapid Venoms _xtherapeutic use
650	0	4	_aGlomerulonephritis _xdrug therapy
650	0	4	_aGuanidines _xtherapeutic use
650	0	4	_aHumans
650	0	4	_aImmunoglobulins, Intravenous _xtherapeutic use
650	0	4	_aMembrane Cofactor Protein
650	0	4	_aMembrane Glycoproteins _xtherapeutic use
650	0	4	_aReceptors, Complement _ximmunology
650	0	4	_aRespiratory Distress Syndrome _xtherapy
650	0	4	_aShock, Septic _xtherapy
773	0		_tMedicina clinica _gvol. 105 _gno. 18 _gp. 700-2
999			_c8537353 _d8537353